Stockscreener 앱 받기
0.3706
5.25%
0.0185
시장 영업 전:
.39
0.0194
+5.23%
Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스
Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions - MSN
Harvard Bioscience (HBIO) Target Price Reduced Amid Market Chall - GuruFocus
Harvard Bioscience (HBIO): Analyst Lowers Price Target, Maintains Rating | HBIO Stock News - GuruFocus
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast By Investing.com - Investing.com South Africa
Harvard Bioscience Announces First Quarter 2025 Financial Results - GlobeNewswire
Harvard Bioscience: Q1 Earnings Snapshot - MySA
Harvard Bioscience (HBIO) Reports Q1 2025 Highlights Amid Financial Challenges - GuruFocus
Transcript : Harvard Bioscience, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com
Harvard Bioscience earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
HBIO Reports Decline in Q1 Revenue Amid Market Challenges | HBIO Stock News - GuruFocus
Harvard Bioscience earnings matched, revenue topped estimates - Investing.com
Harvard Bioscience Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Harvard Bioscience, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HBIO) - Seeking Alpha
Harvard Bioscience Q1 2025 slides: Revenue decline and goodwill impairment weigh on results - Investing.com Canada
Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast - Investing.com
Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Harvard Bioscience Inc Reports Q1 2025 Revenue of $21.8M, Exceed - GuruFocus
Harvard Bioscience Q1 Net Income USD -50.34 Million - marketscreener.com
Harvard Bioscience Announces First Quarter 2025 Financial Results | HBIO Stock News - GuruFocus
Harvard Bioscience : Q1 2025 Harvard Bioscience, Inc. Earnings Conference Call - marketscreener.com
Harvard Bioscience Announces First Quarter 2025 Financial Results - GlobeNewswire Inc.
Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Report Preview: W - GuruFocus
What Is Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Share Price Doing? - Yahoo Finance
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET | HBIO Stock News - GuruFocus
Harvard Bioscience, Inc. to Announce Q1 2025 Financial Results on May 12, 2025 - Nasdaq
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at - Bluefield Daily Telegraph
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET - GlobeNewswire
Harvard Bioscience Sets Date for Q1 2025 Financial Results: What Investors Should Watch - Stock Titan
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET - IT Business Net
Is Now An Opportune Moment To Examine Harvard Bioscience, Inc. (NASDAQ:HBIO)? - simplywall.st
Harvard Bioscience (NASDAQ:HBIO) Coverage Initiated at StockNews.com - American Banking and Market News
Press Release Distribution & PR Platform - ACCESS Newswire
Harvard Bioscience Inc [HBIO] Shares Rise 1.22 % on Wednesday - knoxdaily.com
Did Harvard Bioscience Inc (HBIO) perform well in the last session? - uspostnews.com
Market Watch: Harvard Bioscience Inc (HBIO)’s Noteworthy Gain, Closing at 0.40 - DWinneX
Harvard Bioscience’s Bertrand Loy to Step Down - TipRanks
Benchmark reiterates Harvard Bioscience stock with $4.50 target - Investing.com
Benchmark reiterates Harvard Bioscience stock with $4.50 target By Investing.com - Investing.com India
Harvard Bioscience’s (HBIO) Sector Weight Rating Reiterated at KeyCorp - Defense World
Harvard Bioscience (HBIO) Announces CFO Transition - GuruFocus
Harvard Bioscience Announces CFO Transition | HBIO Stock News - GuruFocus
Harvard Bioscience (HBIO) Sees CFO Transition with Interim Appoi - GuruFocus
Lacklustre Performance Is Driving Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 49% Price Drop - simplywall.st
Harvard Bioscience Appoints Mark Frost as Interim CFO - citybiz
Harvard Bioscience appoints interim CFO amid market challenges By Investing.com - Investing.com Canada
Harvard Bioscience CFO Jennifer Cote Resigns - marketscreener.com
1.71%
0.75%
자본화:
|
볼륨(24시간):